(Press-News.org) Researchers from Lund University in Sweden have identified distinct molecular signatures associated with the clinical signs of sepsis that could provide more accurate diagnosis and prognosis of sepsis, as well as help to target specific therapies at patients who would benefit most, according to new research being presented at this year’s European Congress of Clinical Microbiology and Infectious Diseases (ECCMID 2024) in Barcelona, Spain (27-30 April).
“A simple blood test when combined with a personalised risk model has the potential to save lives by providing more accurate sepsis diagnosis and determining who may go on to develop more severe clinical manifestations", says co-lead author Dr Lisa Mellhammar from Lund University, Sweden. “It’s vital that patients with suspected sepsis are identified prior to the onset of organ failure. Given the challenges associated with timely diagnosis and the fact that sepsis kills millions of people around the world every year, there is an urgent demand for an alternative approach.”
Sepsis is a life-threatening organ-dysfunction triggered by a severe infection. Severe sepsis and septic shock are progressive stages of sepsis, associated with multi-organ failure and death. According to WHO, there were an estimated 49 million sepsis cases and 11 million potentially preventable deaths in 2017—accounting for almost 20% of all global deaths [1].
One of the persistent challenges in treating sepsis is the lack of timely diagnosis, as there is no singular diagnostic test that reliably detects sepsis. Current practices rely on broad-ranged biomarkers such as CRP (C-reactive protein, an inflammation marker), PCT (procalcitonin, a pro-hormone), and lactate for the detection of sepsis.
Additionally, sepsis is a highly variable disease that can arise from a multitude of causes, and despite hundreds of clinical trials there are no targeted treatments, and clinicians currently rely on the broad-spectrum use of antibiotic, antiviral, and antifungal therapies.
“It’s difficult to predict who will get sepsis, who will recover, and who will have poor outcomes”, says co-lead author Dr Adam Linder from Lund University, Sweden. “We urgently need better ways to understand sepsis at the molecular level so we can classify suspected sepsis patients according to the clinical manifestations of their illness and identify high-risk patients and develop more effective treatments.”
In this study, researchers set out to investigate the distinct proteomic signatures (unique patterns of proteins which are associated with immune response in patients with sepsis) associated with different clinical symptoms and outcomes, such as different organ dysfunctions and infections.
They included 1,364 plasma samples from randomly selected adult patients with suspected sepsis admitted to the emergency department at Skåne University Hospital between 1st September 2016 and 31st of March 2023. Overall, 1,073/1,364 patients had an infection, and of these 913 had sepsis.
The researchers used mass spectrometry to analyse the plasma samples and generate comprehensive molecular maps to better understand patterns of proteins that were predictive of septic shock. Each protein panel was then combined into a molecular signature to train a machine-learning model, allowing researchers to predict which patients would develop septic shock with high accuracy (see figure 1a in full abstract).
Patients were then classified into low, medium, or high probability of developing septic shock and the model was able to show how increasing risk was associated with higher mortality (see figure 1b in full abstract).
The researchers also identified panels of proteins that were predictive of six different types of organ dysfunction (cardio, central nervous system, coagulation, liver, kidney, and respiratory) and infection. They analysed the biological processes associated with each panel to show how their unique proteome signatures influence sepsis.
Patients were then classified into five risk categories based on the probabilities of having organ dysfunctions and infection and the risk of dying.
“A fast test that provides more accurate sepsis diagnosis and could also predict who is at greater risk of poorer outcomes now seems a genuine possibility”, says Mellhammar. “Any research like this needs clinical validation and many hurdles must be cleared before these biomarkers are used in the clinic. But we envision this as a tool that could be deployed worldwide, as the future of early detection of sepsis.”
Despite the promising findings, the authors outline some limitations of their study, including that because sepsis is a highly variable disease, it is important that the findings are validated in different cohorts and settings. Additionally, because sepsis is a dynamic syndrome that progresses during the disease, repeated samples need to be taken from sepsis patients to study how the progress from earlier to later states affects the proteome. The authors also note that these data could benefit from further analysis, using for example, transcriptomics.
END
Scientists have a new tool in the race to improve the diagnosis and prognosis of sepsis
Scientists identify unique molecular signatures of sepsis and use AI to improve diagnosis and identify patients most likely to develop severe symptoms and suffer poor outcomes
2024-03-29
ELSE PRESS RELEASES FROM THIS DATE:
UK Biobank study identifies ideal body weight for adults with type 2 diabetes to minimise risk of dying from cardiovascular disease
2024-03-29
*This is an early press release from the European Congress on Obesity (ECO 2024) Venice 12-15 May. Please credit the Congress if using this material*
New research being presented at this year’s European Congress on Obesity (ECO) in Venice, Italy (12-15 May), identifies the optimum body weight range for adults with type 2 diabetes to minimise their risk of dying from any cardiovascular disease, including heart failure, heart disease, stroke, and chronic kidney disease.
The findings, based on health data from the UK Biobank, indicate that for adults aged 65 years or younger, maintaining a body mass index (BMI) within the normal range of 23–25 kg/m² was associated with the ...
Social media images of pediatric craniofacial patients – parents voice concerns
2024-03-29
Waltham — March 29, 2024 — Parents voice strong concerns about social media sharing of images of children undergoing craniofacial surgery, reports a survey study in the April issue of Plastic and Reconstructive Surgery®, the official medical journal of the American Society of Plastic Surgeons (ASPS). The journal is published in the Lippincott portfolio by Wolters Kluwer.
"Pediatric plastic surgeons must understand that consent and assent are necessary before posting patient images online," comments senior author Kenneth L. Fan, MD, of Georgetown ...
Researchers produce grafts that replicate the human ear
2024-03-29
Researchers Produce Grafts that Replicate the Human Ear
Using state-of-the-art tissue engineering techniques and a 3D printer, researchers at Weill Cornell Medicine and Cornell Engineering have assembled a replica of an adult human ear that looks and feels natural. The study, published online in Acta Biomaterialia on March 16, offers the promise of grafts with well-defined anatomy and the correct biomechanical properties for those who are born with a congenital malformation or who lose an ear later in life.
“Ear reconstruction requires multiple surgeries and an incredible amount of artistry ...
Hevolution Foundation issues $115 million call for applications for geroscience research opportunities
2024-03-29
BOSTON, United States — 29 March, 2024 — Based on the success of its 2023 HF-GRO program effort, Hevolution Foundation is issuing a call for applications for the 2024 iteration of the program. HF-GRO is an international effort to accelerate progress in healthy aging research. The major goal is to identify and support research that will further the Hevolution’s mission of extending healthy lifespan for the benefit of all humanity.
HF-GRO will ...
Rice study identifies protein responsible for gas vesicle clustering in bacteria
2024-03-29
HOUSTON – (March 29, 2024) – Gas vesicles are hollow structures made of protein found in the cells of certain microorganisms, and researchers at Rice University believe they can be programmed for use in biomedical applications.
“Inside cells, gas vesicles are packed in a beautiful honeycomb pattern. How this pattern is formed has never been thoroughly understood. We are presenting the first identification of a protein that can regulate this patterning, and we believe this will be a milestone in molecular microbiology,” said George Lu, assistant professor of bioengineering and a Cancer Prevention and Research Institute of Texas scholar.
Lu and colleagues have published ...
AADOCR announces recipients of the 2024 Student Competition for Advancing Dental Research Application (SCADA)
2024-03-29
Alexandria, VA – The American Association for Dental, Oral, and Craniofacial Research (AADOCR) has named the recipients of the 2024 Student Competition for Advancing Dental Research Application (SCADA). The recipients were recognized during the Opening Ceremonies of the 53rd Annual Meeting of the AADOCR, which was held in conjunction with the 102nd General Session of the International Association for Dental, Oral, and Craniofacial Research and the 48th Annual Meeting of the Canadian Association for Dental Research, on March 13-16, 2024 in New Orleans, LA.
The winners are:
CLINICAL RESEARCH & PUBLIC HEALTH CATEGORY
1st ...
Veterans help provide greater insight into Klinefelter and Jacobs syndromes
2024-03-29
AURORA, Colo. (March 29, 2024) –Researchers at the University of Colorado Anschutz Medical Campus and collaborators across the country have conducted the largest and most diverse study of men with extra X or Y chromosomes in the US using a large dataset of military veterans. The results could lead to better diagnoses of these underrecognized conditions and earlier treatment of associated diseases.
The study was published today in JAMA Network Open.
“One in 400 males have an additional X or Y chromosome, however 86 percent of these individuals are not diagnosed,” said ...
Three renowned Argonne scientists accept joint appointments at the University of Houston
2024-03-29
HOUSTON, March 29, 2024 – Three top researchers with the U.S. Department of Energy’s Argonne National Laboratory have accepted joint appointments in various capacities at the University of Houston. These appointments are part of the memorandum of understanding (MoU) Argonne signed recently with the Greater Houston Partnership. The MoU creates greater collaboration across academia, industry, private investors and government to accelerate and scale decarbonization efforts in the region, with the goal of achieving a net-zero emissions economy by 2050, according to an Argonne press release.
“This strategic collaboration leverages the combined strengths ...
High-resolution images reveal similarities in protein structures between Alzheimer’s disease and Down syndrome
2024-03-29
INDIANAPOLIS – More than 90% of people with Down syndrome, the most common chromosomal disorder in humans and the most frequent genetic cause of intellectual disability, are diagnosed with Alzheimer’s disease by ages 55-60. A new study recently published in Nature Structural and Molecular Biology uses leading-edge cryo-electron microscopy imaging technology to determine whether differences exist between the protein structures in those with Alzheimer’s disease and those with both Alzheimer’s disease and Down syndrome.
“Just like in Alzheimer’s disease, the neuropathological phenotype in those with ...
How blocking a neural receptor responsible for addiction could reduce alcohol use
2024-03-29
LA JOLLA, CA—Scripps Research scientists have found that LY2444296—a compound that selectively blocks the kappa opioid receptor (KOP)—may reduce drinking in cases of alcohol dependence in animal studies. The findings, which were published March 9, 2024, in Scientific Reports, could eventually inform new treatment options for people who experience alcohol use disorder (AUD).
“Compounds designed to selectively block the KOP are very promising because this receptor is involved in a lot of mental illnesses, such as ...
LAST 30 PRESS RELEASES:
Breaking new ground in health care: Setting the standard for XR clinical research with the RATE-XR guideline
Unlocking worm strategies: A path to innovative vaccines and therapies
Students are less likely to feel safe at their schools, compared to staff and parents
SwRI announces joint industry program aimed at advancing heavy-duty hydrogen refueling infrastructure
Webb telescope’s largest study of universe expansion confirms challenge to cosmic theory
By age six, children think boys are better than girls at computing and engineering, new American Institutes for Research study shows
Hair growth drug safe at low doses for breast cancer patients
Giving a gift? Better late than never, study finds
Judging knots throws people for a loop
Not so simple machines: Cracking the code for materials that can learn
Finding the weak points: New method to prevent train delay cascades
New AI cracks complex engineering problems faster than supercomputers
Existing EV batteries may last up to 40% longer than expected
Breakthrough AI model can translate the language of plant life
MASH discovery redefines subtypes with distinct risks: shaping the future of fatty liver disease treatment
Three-quarters of Earth’s land became permanently drier in last three decades: UN
Lower-quality public housing is at high risk of flood damage
Study compares soft tissue sarcoma rates among U.S. military servicemen and men in the general population
Toxic air in Texas high schools
What motivates Americans to eat less red meat?
Sugary drinks significantly raise cardiovascular disease risk, but occasional sweet treats don’t, scientists find
Falsifying anthropics
New West Health-Gallup poll reveals most Americans worried about often hidden healthcare fees
Developing wastewater treatment units that treat right where it's generated
Children’s Hospital of Philadelphia researchers find rotavirus vaccine is safe for use in NICU babies
New international guidelines announced for Premature Ovarian Insufficiency (POI)
Supporting parents through “unimaginable pain” of losing child – new toolkit developed for clinicians involved in Child Death Review
Could online technology be a clue as to why boys in Norway are outperforming girls in learning English as a second language?
A healthy diet helps the weighty battle with chronic pain
ASH 2024: Antibody shows encouraging results for treating high-risk follicular lymphoma and marginal zone lymphoma
[Press-News.org] Scientists have a new tool in the race to improve the diagnosis and prognosis of sepsisScientists identify unique molecular signatures of sepsis and use AI to improve diagnosis and identify patients most likely to develop severe symptoms and suffer poor outcomes